Glucose is a necessary source of energy to sustain cell activities and homeostasis in the brain, and enhanced glucose transporter (GLUT) activities are protective of cells during energy depletion including brain ischemia. Here we investigated whether and if so how the astrocytic expression of GLUTs crucial for the uptake of glucose changes in ischemic conditions. Under physiological conditions, cultured astrocytes primarily expressed GLUT1, and GLUT3 was only detected at extremely low levels.
Introduction
Energy-independent glucose transporters (GLUTs), which contain 12 membrane-spanning domains and span the plasma membrane, mediate the entry or exit of glucose. Thirteen facilitative GLUTs have been identified (Wood and Trayhurn, 2003) , the predominant cerebral GLUTs being GLUT1 and GLUT3. GLUT2, GLUT4, GLUT5, and GLUT7 have also been detected at low levels in the brain (Vannucci et al., 1997) . Under physiological conditions, GLUT1 is mainly expressed at plasma membranes in astrocytes, and GLUT3 is expressed not in astrocytes but in neurons (Maher et al., 1994) . The parameters of neuronal GLUT3 activities such as kinetics or catalytic center activity (CCA) determined by conducting assays using a non-metabolizable glucose analog show that the entry-mode velocity (CCA value) of GLUT1 and GLUT3 is 123 and 853 (s -1 ), respectively, revealing that GLUT3 transports extracellular glucose about 7 times faster than GLUT1 (Maher et al., 1996) . GLUT3 only takes up extracellular glucose: it does not release intracellular glucose to the extracellular space even if the intracellular glucose concentration is higher than the extracellular concentration. Therefore, it seems reasonable that neurons strongly express GLUT3 under physiological conditions, because glucose is a necessary source of energy to sustain neuronal activities.
A number of studies have demonstrated that enhanced glucose transporter activities are protective of cells during energy depletion (Vannucci et al., 1997; Vannucci et al., 1998; Yu et al., 2008) . Hypoxic insults increase GLUT1 mRNA and protein levels in astrocytic cultures, Neurochemistry International 5 and sublethal hypoxic insults, i.e., hypoxic preconditioning, up-regulates the expression of neuronal GLUT1 and GLUT3 mRNA as well as astrocytic GLUT1 mRNA, leading to the development of hypoxic tolerance (Vannucci et al., 1998) . However, it is still unknown whether GLUT3 is actually expressed in astrocytes under pathological conditions or not.
Astrocytes are reactive in response to ischemic stress: they become hypertrophic and glial fibrillary acidic protein (GFAP) expression is increased. Such reactive astrocytes possibly contribute to the induction of neuronal migration or the growth of axons during development (Rakic, 1971) , and have a protective role in the central nervous system under pathological conditions (Li et al., 2008) . Our previous study showed that the exposure of cultured astrocytes to sublethal ischemia, preconditioning (PC), results in a marked increase in GFAP, and such astrocytes have increased resistance to subsequent lethal ischemic stress (Iwabuchi and Kawahara, 2009 ). In contrast, controversial results suggest that reactive astrocytes interfere with axonal regeneration in the injured spinal cord (Brown and Mc, 1947) . In addition, it is unclear whether changes in the expression and activity of GLUT3 are involved in the PC-induced ischemic tolerance in astrocytes.
In this study, we found that in cultured astrocytes, the expression of GLUT3 increased under ischemic conditions, and the increase was responsible for an increase in the amount of glycogen deposited during reperfusion, contributing to the development of resistance to subsequent lethal ischemic stress. 
Materials and methods

Cell culture
The animal experiments were carried out in accordance with The Guide for the care and use of laboratory animals, Hokkaido University School of Medicine. The methods used to obtain primary astrocytic cultures were described previously in detail (Iwabuchi and Kawahara, 2011; Kawahara et al., 2002) . In brief, the cortical hemispheres of postnatal 2 to 3-day-old rats, were isolated and digested at 37 °C for 30 min with a 0.01% papain-cysteine solution. Primary astrocytes were plated onto polyethyleneimine-coated glass coverslips/plastic dishes at 20,000 cells/cm 2 . Cells were maintained with a culture medium (CM) (80% Dulbecco's modified Eagle's medium (Gibco, Grand Island, USA) supplemented with 10% Ham's F-12 nutrient mixture and 10% fetal bovine serum) with 1% penicillin/streptmycin at 37 °C in a 5% CO 2 incubator.
Cultured astrocytes were fed a cooled CM twice a week. The experiments were performed with cultures maintained for 14-21 days.
Oxygen-glucose deprivation (OGD)
Cultures were washed two times with a glucose-free balanced salt solution 
5'-TGTCATTATCTCGGAGCTCATCT-3', (probe) 5'-CTCCTCCA-3'],
5'-CCTGGAGA-3']. AmpliTaq Gold® PCR Master Mix (Life Technologies, California, USA) was added to each sample, and then cDNA was amplified with a thermal cycler. -actin was used as the housekeeping gene to standardize GLUT1, GLUT3, and NF-B mRNA levels.
Western blot analysis
Western blotting was performed as described previously in detail Kawahara, 2009, 2011) . In brief, cell lysate in a sodium dodecyl sulfate (SDS) sample buffer was electrophoresed on SDS Tris-HCl gels (DRC, Tokyo, Japan), and transferred to PVDF membranes (Amersham, Arlington
Heights, USA). The blots were blocked, and specific proteins were detected by using as primary antibodies, anti-rabbit IgG anti-GLUT1 (IBL, Gunma, Japan; 1:1000), GLUT3 (Abcam, Cambridge, UK; 1:1000) and anti-mouse were visualized using an enhanced chemiluminescence system (NEN Life Science Products, Boston, USA). Quantification of the immunoreactive bands was done with Scion Image for Windows (Scion Corporation, Frederick, USA). Quantitative evaluation of the expression of each protein was performed as described (Iwabuchi and Kawahara, 2009 ). We measured the density of these bands, and calculated the rate for total -actin in control or OGD groups. We took the values in control groups to be 100%, and then calculated the rate in OGD groups.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde and washed with Tokyo, Japan). The image analysis was identical for each culture. In single astrocytic cultures, more than 94% cells were astrocytes as described previously (Iwabuchi and Kawahara, 2009; Kawahara et al., 2002 ).
RNA interference
RNA interference for newly synthesized GLUT3 mRNA was performed with the use of small interfering RNA, mouse GLUT3 (Santa Cruz Biotechnology, California, USA). When astrocytes were about 80% confluent, the CM was replaced with a penicillin/streptomycin-free CM and cultured for 1 day. siRNA Transfection Reagent mixture [about 98%
siRNA Transfection Medium (Santa Cruz Biotechnology) with 0.6-0.8% GLUT3 siRNA or Control siRNA (Santa Cruz Biotechnology) supplemented with 0.8% siRNA Transfection Reagent (Santa Cruz
Biotechnology)] was added to the cultures and incubated for 8 hours. Then CM containing 2 times the volume of fetal bovine serum was added and cultures were incubated for 1 day. Finally, the CM was aspirated and replaced with fresh CM for 1day.
Cell survival assay
Cell viability was assessed by the 3-(4,5-Dimethyl 2-thiazol)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay (DOJINDO Laboratories, Kumamoto, Japan), which is based on the reduction of the yellow MTT tetrazolium salt by mitochondrial dehydrogenases to form a blue MTT formazan. A MTT dissolved-solution was added to each well and incubated for 3 h, and the medium was removed completely and a 40 mM HCl-isopropanol lysis buffer was added. The optical density of each well at 560 nm was determined using a microplate reader (Infinite ® 200; Tecan Austria GmbH).
Data analysis
The data are expressed as the mean ± standard error of the mean (S.E.M.).
Comparisons were performed using the ANOVA followed by a paired Student's t-test or Student's t-test alone. Differences at p < 0.05 were considered significant.
Results
OGD-induced increase in astrocytic GLUT3 expression
The Real-time PCR analysis showed that both GLUT1 and GLUT3 mRNA levels increased significantly during the simulated ischemia (oxygen and glucose deprivation: OGD) (Fig.1A&B ). The expression of GLUT1 mRNA increased with the duration of OGD. GLUT1 mRNA was readily detected in cultured astrocytes in the control group; however, astrocytic GLUT3 mRNA was rarely detected (0.00007 ± 0.0001, mean ± S.E.M.). In contrast to GLUT1 mRNA, the relative GLUT3 mRNA levels were significantly higher at 1 h of OGD (0.002 ± 0.09, mean ± S.E.M.) than 2 h of OGD (0.007 ± 0.002).
The Western blot analysis revealed that the expression of the 50kDa
form of GLUT1 at 2 h of OGD was 147.3 ± 17.3% (mean ± S.E.M.), and a significant increase in GLUT1 expression was observed as compared to the control groups (100.0 ± 6.4%) (Fig.1C, white bars) . The expression of the 54kDa form of GLUT3 in OGD groups was also significantly increased, by 2.3-fold (Fig.1C, black bars) . To further confirm the OGD-induced increase in GLUTs expression in astrocytes, an immunofluorescent analysis was performed. Two hours of OGD treatment enhanced both GLUT1 and GLUT3-positive reactions (green) as compared to the control (Fig.1D ).
The transcription factor NF-B regulates the increase in GLUT3 expression
It has been reported that the activation of an IB-nuclear factor-B (NF-B) pathway causes the upregulation of GLUT3 mRNA expression in mouse embryonic fibroblasts (Kawauchi et al., 2008) . In addition, endothelin-1's induction of GLUT1 transcription is mediated by NF-B in cultured adipocytes (Kao and Fong, 2008) . Therefore, we speculated that NF-B might regulate the synthesis of astrocytic GLUTs during OGD. An inhibitor of IKK and IKK, wedelolactone (50 M), was added to the glucose-free BSS and the cultures were exposed to OGD. As expected, the increase in both GLUT1 ( Fig.2A) and GLUT3 (Fig.2B ) mRNA levels was significantly attenuated in the OGD groups treated with wedelolactone.
Western blotting and immunofluorescence analyses revealed that wedelolactone significantly suppressed astrocytic GLUTs expression in the OGD groups (Fig. 2C&D) . Notably, the increase in GLUT3 expression was strongly attenuated by wedelolactone treatment [OGD2h with or without wedelolactone: 32.4 ± 5.5 or 100.0 ± 1.4% (mean ± S.E.M.)]. Fig. 2E shows that OGD significantly increased NF-B mRNA levels as compared to the control, and the increase was dependent on the duration of OGD.
Wedelolactone itself inhibited the synthesis of NF-B mRNA (Fig. 2E) .
When an inhibitor of protein synthesis, cycloheximide (50 M), was added to the BSS and exposed to OGD, both mRNA and protein levels of GLUTs were significantly decreased ( Fig. 2A-2D ).
Functional significance of GLUT3 expression in astrocytes
Treatment of astrocytes with GLUT3 siRNA resulted in a significant decrease of GLUT3 expression as revealed by both Western blot and immunocytochemical analyses (Fig. 3A&B) . The intracellular glycogen levels at 1 h reperfusion after OGD were significantly lower than control values (Fig. 3C) . However, the levels at 1 day of reperfusion after OGD were significantly increased as compared to the control. In contrast, the increase in intracellular glycogen was suppressed in the GLUT3 siRNA-treated groups. We then investigated whether the increase in intracellular glycogen deposition was involved in the protection of astrocytes from subsequent lethal ischemic stress. After 1 day of reperfusion following 2 h of OGD, the cultures were again exposed to OGD stress. As shown in Fig. 3D , preconditioned (PC) astrocytes exhibited resistance to subsequent lethal OGD. Eight hours of lethal OGD significantly increased astrocytic cell damage as compared to that in the PC astrocytes. The PC-induced increased resistance was significantly attenuated in cells treated with GLUT3 siRNA. In addition, GLUT3
siRNA treatment did not affect the expression of GLUT1 mRNA and protein (Fig. 4) , further supporting our inference that the PC-induced increase in GLUT3 was crucial to the increased glucose uptake, leading to the development of resistance to lethal ischemia.
Discussion
Ischemic stress induces GLUT3 expression via NF-B's signaling pathways
Our findings demonstrate that astrocytes enhance not only GLUT1 but also Immediately after anoxic or ischemic insults, stressed neurons increase their own GLUT3 gene expression, and additionally, enhanced GLUT1 mRNA expression is also observed (Vannucci et al., 1998; Yu et al., 2008) .
These phenomena imply that glucose transport is critical for neurons to survive under pathological conditions. In contrast, glucose is mainly taken up through GLUT1 in astrocytes. When the extracellular concentration of glucose is low, astrocytes also increase their GLUT1 mRNA both in vivo and in vitro (Vannucci et al., 1998; Yu et al., 2008) , suggesting this inherent response to be pivotal for astrocytes to avoid acute or delayed cell death under anoxic or ischemic conditions. In addition, GLUT3 mRNA is not detectable in astrocytes after hypoxic stress (Yu et al., 2008) . However, using established techniques for anoxic or ischemic insults, the loading period for the anoxic gas mixture is generally determined by the neuronal response to the stress, i.e., the stress is sublethal or lethal to neurons, but these conditions may be less than sublethal to astrocytes.
Contrary to in previous studies (Vannucci et al., 1998; Yu et al., 2008) , GLUT3 protein was detected at low levels in control astrocytes (Fig.1) . The immunofluorescent analysis also showed the translocation of GLUT3 from the cytoplasm to plasma membrane after OGD ( Fig. 1D: lower figure) .
Though primary neurons were used as GLUT3-positive controls, we initially suspected that the antibody used was not specific to the GLUT3 protein. Therefore, a Western blot analysis of GLUT3 expression with another anti-GLUT3 antibody (IBL, Gunma, Japan) was performed.
Nevertheless, GLUT3 expression was similarly observed in the control groups although the expression was low, and 2 h of OGD increased the level about 1.3 fold (data not shown). Additional evidence for the enhancement of astrocytic GLUT3 expression comes from another report.
Cidad P et al. showed that the endotoxin lipopolysaccharide (LPS) increased intracellular nitrite (NO 2 -) concentrations, and GLUT3 expression in rat astrocytic cultures was enhanced, leading to an increase in glucose uptake activity (Cidad et al., 2001 ). These results seem meaningful, but the astrocytic cytotoxicity of LPS (1 g/mL) and signal transduction regulating the GLUT3 gene are unknown. The transcription factor Sp1 or NF-B seems to play an important role in the regulation of the GLUT1 gene.
Vasoconstrictor Endothelin-1 (ET-1) induced GLUT1 gene expression via PKC or MAPK signaling pathways through Sp1 and NF-B in 3T3-L1
adipocytes (Kao and Fong, 2008) . In addition, some oncogenes down-regulate p53 activity, leading to the activation of IKK or IKK and to NF-B downstream, resulting in the up-regulation of GLUT3 gene expression (Kawauchi et al., 2008) . In the present study, NF-B mRNA levels increased markedly during OGD, and wedelolactone (50 M) treatment induced significant decreases in GLUTs mRNA and protein, and the protein synthesis inhibitor cycloheximide (100 M) also suppressed GLUTs expression (Fig. 2) . These results suggest that NF-B's signaling pathways contribute to the increase in not only mRNA but also protein levels of GLUT3 in astrocytic cultures. Further research is needed to investigate how levels of NF-B mRNA induce GLUT3 expression since the transcription factor regulates both GLUT1 and GLUT3.
Functional significance of the ischemia-induced increase in GLUT3 expression
Astrocytes could transport extracellular glucose through enhanced GLUT activities when they were recovered from the OGD. The glucose was quickly consumed to recover or sustain the homeostasis of cells; therefore, intracellular glycogen levels might be lower at 1 h of reperfusion (Fig. 3C ).
The amount of glycogen was significantly increased at 1 day of reperfusion as compared to the control. The results imply that inducible GLUT3 might support GLUT1 activities, leading to the enhancement of glucose uptake into the astrocytes during reperfusion after ischemia. When astrocytes were treated with siRNA for GLUT3 mRNA, the ischemia-induced increase in intracellular glycogen was significantly attenuated: the intracellular glycogen levels in siGLUT3-treated astrocytes were not significantly different to those in cells of the control groups (Fig. 3C) . These results are unexpected since GLUT1 mRNA levels were more increased after OGD as compared to GLUT3 mRNA levels ( Fig. 1) , and the primary GLUT in astrocytes is GLUT1; therefore, we speculated that the increase in glycogen was mainly regulated by enhanced GLUT1 expression, and inducible GLUT3 expression might make a slight contribution. To understand the precise role of GLUTs in glycogen deposition under pathological conditions, additional experiments using siRNA for GLUT1 mRNA are needed.
The question then arises as to why astrocytes need to accumulate much more intracellular glycogen under pathological conditions. Our previous report indicates many strongly GFAP-positive astrocytes at 1 day of reperfusion after 2 h of OGD, and that such reactive astrocytes are more resistant to subsequent lethal OGD (Iwabuchi and Kawahara, 2009) .
Ischemic resistance to 8 h of lethal OGD was also seen in astrocytes treated with scrambled RNA for GLUT3 mRNA (siCont), but the tolerance was significantly attenuated in cells treated with siGLUT3 (Fig. 3D ). These findings suggest extracellular glucose to be transported through enhanced-GLUT3 activity early in the reperfusion after OGD, leading to the acceleration of glycogen synthesis and/or storage during 1 day of reperfusion, and much glycogen to be available to resist against subsequent lethal OGD. Further studies are needed to investigate whether ischemic stress enhances astrocytic GLUT3 expression and increases the intracellular glycogen store in an in vivo ischemic model. Astrocytes with ischemic tolerance would survive under severe ischemic conditions, and probably contribute to the protection of neurons from ischemic damage in the brain. GLUT1-positive astrocytes (green) and their nuclei (HE, blue) in the
